Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

News and Events

NewsEvents

IP in the digital age: a tricky path ahead for pharma companies

Date: 20 September 2016

James Cross, Partner at Maucher Jenkins, has contributed to an article published by Life Sciences Intellectual Property Review concerning IP protection in the world of digital health and the need for pharmaceutical companies to adjust in the digital age.

 

You can read the full article from LSIPR by clicking here

C
This site uses cookies.

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy

Necessary Cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytical Cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

x